del Valle Hector F, Lascano Elena C, Negroni Jorge A
Department of Physiology, Pharmacology and Biochemistry, Favaloro University, Buenos Aires, Argentina.
Cardiovasc Res. 2002 Aug 15;55(3):642-59. doi: 10.1016/s0008-6363(02)00468-6.
Sarcolemmal and mitochondrial ATP-sensitive potassium (KATP) channels have been postulated to participate in preconditioning protection against infarction and stunning. However, these structures appear to be altered in diabetes and thus, it would be possible that preconditioning does not develop in diabetic hearts.
The purpose of this study was to know whether early (EP) and late (LP) ischemic preconditioning against stunning develop in conscious diabetic (D) sheep and whether diabetes affects KATP channel function.
Male castrated sheep received alloxan monohydrate (1 g) and were ascribed to three experimental groups: control [DC, 12 min of ischemia (i) followed by 2 h of reperfusion (r)], early preconditioning (DEP, six 5 min i-5 min r periods were performed 45 min before the 12 min i) and late preconditioning (DLP, same as DEP except that the preconditioning stimulus was performed 24 h before the 12 min i). Regional mechanics during reperfusion was evaluated by wall thickening fraction (%WTH) and expressed as percentage of basal values (100%), and KATP channel behavior was indirectly assessed by monophasic action potential duration (MAPD) in relation to its sensitivity to glibenclamide blockade (0.1 and 0.4 mg/kg). The results were compared to those obtained in normal (N) sheep. The effects of sarcolemmal and mitochondrial KATP channel blockade on recovery from stunning were assessed by administration of glibenclamide (0.1 and 0.4 mg/kg) and 5-hydroxydecanoate (5-HD, 5 mg/kg i.v.) and/or diazoxide (10 microg/kg/min over 90 min). Whether acute hyperglycemia (H) in normal animals and insulin (I) treatment in diabetic sheep affected preconditioning protection and KATP channel behavior were also evaluated.
Results expressed as mean % recovery of %WTH showed that preconditioning protected against stunning in normal sheep (NC=65+/-3.5, NLP=82+/-6**, NEP=76+/-4*, *P<0.05 and P<0.01 against NC) while this did not occur in diabetic ones, where DLP (58+/-7.6) afforded a similar recovery to DC (54+/-5) and DEP worsened instead of improving mechanical function (37+/-9, P<0.01 against DC). Acute hyperglycemia did not affect preconditioning development (NEPH=72+/-3 and NLPH=80+/-4) and insulin treatment reverted the lack of early and late preconditioning protection in diabetic hearts (DEPI=72+/-4 and DLPI=76+/-3, P<0.05 against DC). Sarcolemmal KATP channel behavior appeared altered in diabetic hearts as shown by MAPD in normal sheep (276+10 ms) compared to diabetic ones (365+9 ms, P<0.05) and by the sensitivity to glibenclamide [0.1 mg/kg completely blocked KATP channels in diabetic (P<0.05) but not in normal hearts]. Insulin also restored MAPD in diabetic heart. Mitochondrial KATP channels appeared not to account for the reported results in diabetes, since glibenclamide (%WTH=40+/-4, P<0.01 vs. NC), but not 5HD nor diazoxide affected myocardial functional recovery during reperfusion.
Sarcolemmal KATP channel dysfunction due to the lack of insulin affords a primary approach to explain the absence of preconditioning protection against stunning in diabetic sheep hearts.
肌膜和线粒体的三磷酸腺苷敏感性钾(KATP)通道被认为参与了针对梗死和心肌顿抑的预处理保护。然而,这些结构在糖尿病中似乎发生了改变,因此,糖尿病心脏可能无法产生预处理。
本研究的目的是了解清醒的糖尿病(D)绵羊是否会出现针对心肌顿抑的早期(EP)和晚期(LP)缺血预处理,以及糖尿病是否会影响KATP通道功能。
雄性去势绵羊接受一水合阿脲(1 g),并被分为三个实验组:对照组[DC,缺血(i)12分钟,随后再灌注(r)2小时]、早期预处理组(DEP,在12分钟缺血前45分钟进行6次5分钟缺血-5分钟再灌注周期)和晚期预处理组(DLP,与DEP相同,只是预处理刺激在12分钟缺血前24小时进行)。再灌注期间的局部力学通过室壁增厚分数(%WTH)进行评估,并表示为基础值(100%)的百分比,KATP通道行为通过单相动作电位持续时间(MAPD)与其对格列本脲阻断(0.1和0.4 mg/kg)的敏感性间接评估。将结果与正常(N)绵羊获得的结果进行比较。通过给予格列本脲(0.1和0.4 mg/kg)和5-羟基癸酸(5-HD,5 mg/kg静脉注射)和/或二氮嗪(10 μg/kg/min,持续90分钟)评估肌膜和线粒体KATP通道阻断对心肌顿抑恢复的影响。还评估了正常动物的急性高血糖(H)和糖尿病绵羊的胰岛素(I)治疗是否影响预处理保护和KATP通道行为。
以%WTH的平均恢复百分比表示的结果表明,预处理可保护正常绵羊免受心肌顿抑(NC = 65±3.5,NLP = 82±6**,NEP = 76±4*,*P<0.05,*P<0.01,与NC相比),而糖尿病绵羊则未出现这种情况,其中DLP(58±7.6)的恢复情况与DC(54±5)相似,DEP反而使机械功能恶化而非改善(37±9,与DC相比P<0.01)。急性高血糖不影响预处理的发生(NEPH = 72±3和NLPH = 80±4),胰岛素治疗可逆转糖尿病心脏早期和晚期预处理保护的缺失(DEPI = 72±4和DLPI = 76±3*,与DC相比P<0.05)。与糖尿病绵羊(365±9 ms,P<0.05)相比,正常绵羊的MAPD显示糖尿病心脏中的肌膜KATP通道行为似乎发生了改变,并且对格列本脲的敏感性[0.1 mg/kg可完全阻断糖尿病心脏中的KATP通道(P<0.05),但不能阻断正常心脏中的KATP通道]。胰岛素也恢复了糖尿病心脏中的MAPD。线粒体KATP通道似乎不能解释糖尿病中的报道结果,因为格列本脲(%WTH = 40±4,与NC相比P<0.01),但5HD和二氮嗪均不影响再灌注期间的心肌功能恢复。
由于缺乏胰岛素导致的肌膜KATP通道功能障碍为解释糖尿病绵羊心脏中缺乏针对心肌顿抑的预处理保护提供了一个主要途径。